发明名称 NOVEL NUCLEOSIDE ANALOGS
摘要 Novel oligonucleotide analogs are provided having improved cellular uptake, improved resistance to nucleases, and good hybridization to target RNA. Such analogs are provided having substantially non-chiral, non-ionic linking functionalities between the sugars and sugar analogs thereof. In accordance with preferred embodiments, the 4' position of a sugar or sugar analog at one nucleoside is linked to the 3' position of a second sugar or sugar analog of a second nucleoside by a linking function that comprises a two- or three- carbon backbone chain. In accordance with preferred embodiments, the linking functions comprise the formula)-R1-O where R1 comprises a two or three carbon backbone. Such linking functions also, preferably comprise ether functionalities to effect such linkage. Processes for the automated synthesis of oligonucleotide analogs are also provided.
申请公布号 EP0544792(A4) 申请公布日期 1994.07.27
申请号 EP19910915853 申请日期 1991.08.12
申请人 ISIS PHARMACEUTICALS, INC. 发明人 COOK, PHILIP, DAN;SANGHVI, YOGESH, SHANTILAL
分类号 C07F9/6568;C07D405/04;C07D405/14;C07F7/18;C07H19/04;C07H19/06;C07H19/10;C07H19/16;C07H21/00;C12N15/09 主分类号 C07F9/6568
代理机构 代理人
主权项
地址